Jazz Pharmaceuticals (JAZZ) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -593.00 |
| Dec 31, 2025 | -528.00 |
| Sep 30, 2025 | -378.00 |
| Jun 30, 2025 | -539.00 |
| Mar 31, 2025 | -545.00 |
| Dec 31, 2024 | -575.00 |
| Sep 30, 2024 | -374.00 |
| Jun 30, 2024 | -355.00 |
| Mar 31, 2024 | -304.00 |
| Dec 31, 2023 | -507.00 |
| Sep 30, 2023 | -396.00 |
| Jun 30, 2023 | -238.00 |
| Mar 31, 2023 | -593.00 |
| Dec 31, 2022 | -1,143.00 |
| Sep 30, 2022 | -569.00 |
| Jun 30, 2022 | -484.00 |
| Mar 31, 2022 | -687.00 |
| Dec 31, 2021 | -670.00 |
| Sep 30, 2021 | -1,015.00 |
| Jun 30, 2021 | -902.00 |
| Mar 31, 2021 | 98.00 |
| Dec 31, 2020 | -49.00 |
| Sep 30, 2020 | 129.00 |
| Jun 30, 2020 | 130.00 |
| Mar 31, 2020 | 368.00 |
| Dec 31, 2019 | 270.00 |
| Sep 30, 2019 | 267.00 |
| Jun 30, 2019 | 408.00 |
| Mar 31, 2019 | 576.00 |
| Sep 30, 2018 | 466.00 |
| Jun 30, 2018 | 502.00 |
| Mar 31, 2018 | 620.00 |
| Dec 31, 2017 | 824.00 |
| Sep 30, 2017 | 1,086.00 |
| Jun 30, 2017 | 241.00 |
| Mar 31, 2017 | 131.00 |
| Dec 31, 2016 | -386.00 |
| Sep 30, 2016 | -178.00 |
| Jun 30, 2016 | -152.00 |
| Mar 31, 2016 | -208.00 |
| Dec 31, 2015 | -624.00 |
| Sep 30, 2015 | -216.00 |
| Jun 30, 2015 | -10.00 |